February 7, 2014
The landscape of hepatitis C (HCV) management has undergone a near-fundamental transformation over the past couple of years. As new treatment options puff up like popcorn kernels on a hot stove and our understanding of the virus deepens, it's important to revisit what's changed -- and what further changes 2014 may hold in store.
Late in 2013, Andrea Cox, M.D., Ph.D., an associate professor of medicine at Johns Hopkins University School of Medicine, presented an update on HCV coinfection for an audience of HIV care providers. Read on for a summary of key points from her talk, including selected slides (which have been reposted with her permission).
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|What's the Next Big Question in HIV Treatment?|
|Coverage of IAS 2015: The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention|
|The Day the HIV Treatment Pendulum Stopped Swinging|
|New Antiretrovirals, New Formulations and New Strategies for HIV Treatment|
|Same-Day Antiretroviral Therapy on Diagnosis: The Future Model for HIV Care|
|Long-Term HIV Remission Case Raises More Questions Than Answers|